Litcius/Paper detail

PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer

Tianyi Jiang, Xiaofan Feng, Fang Zheng, Xiao-Wen Cui, Yun‐Kai Lin, Yufei Pan, Chun Yang, Zhiwen Ding, Yongjie Zhang, Yexiong Tan, Hongyang Wang, Liwei Dong

2020Cancer Letters32 citationsDOI

Topics & Concepts

PTENBortezomibCancer researchBiologyProteasomeProteasome inhibitorGallbladder cancerCancerPI3K/AKT/mTOR pathwayImmunologyGeneticsSignal transductionMultiple myelomaCholangiocarcinoma and Gallbladder Cancer StudiesCancer Mechanisms and TherapyPeptidase Inhibition and Analysis
PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer | Litcius